Delivery Order SPE2DB20D3303-SPE2DB25FA3TA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.20 for Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.09 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 21, 2025, with completion expected by August 22, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $2,015.06 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion deadline of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,527.97 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems as part of comprehensive...
- The Defense Logistics Agency awarded a $4,373.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens with a July 28, 2025 completion date. This non-set-aside award represents a single delivery order under AmerisourceBergen's broader contract vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within...
- The Defense Logistics Agency awarded a $2,710.74 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a prescription diabetes medication commonly used to support military and veteran healthcare...
- The Defense Logistics Agency awarded a $1,160.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive award, which includes no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a $2,411.34 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens (0.5 mL), with an ultimate completion date of May 7, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3TADelivery Order
The Defense Logistics Agency awarded a $6,486.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on September 16, 2025, with an ultimate completion date of September 17, 2025. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems. This non-set-aside competitive award was performed in Conshohocken, Pennsylvania, the company's corporate headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare programs. The company's primary IDC vehicle enables supply of a comprehensive range of pharmaceuticals, specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations globally. This delivery order exemplifies the company's role as a primary pharmaceutical supplier within the DLA's medical supply chain, fulfilling routine pharmaceutical needs across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/16/25 |